06996.HK
Antengene Corporation Limited
HKSE · Healthcare · Biotechnology · CN
HKD 2.83
−0.53%Forward multiples
Based on analyst estimates
- P/E forward
- 12.40x
- P/E 2026E
- 5.36x
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 4.65x
Trailing multiples
Trailing twelve months
- P/E TTM
- 29.99x
- PEG TTM
- 0.21x
- Price / book
- 1.65x
- Price / sales
- 2.69x
- Price / cash flow
- -20.64x
Enterprise value
- Enterprise value
- HKD 1.2B
- EV / sales
- 1.78x
- EV / EBITDA
- 5.75x
- EV / EBIT
- 6.39x
- Market cap
- HKD 1.8B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026